封面
市場調查報告書
商品編碼
1325135

氧化壓力檢測的全球市場

Oxidative Stress Assays

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年,全球氧化壓力檢測市場規模將達到 19 億美元

隨著 COVID-19 後商業環境的變化,氧化壓力檢測的全球市場預計 2022 年為 9.716 億美元,預計到 2030 年將達到 19 億美元。預計將以 8.5% 的年複合成長率成長消耗品是本報告分析的細分市場之一,預計年複合成長率為 9.3%,到分析期結束時將達到 11 億美元。鑑於疫情后持續復甦,未來八年設備業務的複合年複合成長率調整為7.2%。

美國市場預計將成長2.888億美元,中國年複合成長率為7.8%

到 2022 年,美國氧化壓力檢測市場預計將達到 2.888 億美元。中國是世界第二大經濟體,預計到2030年市場規模將達到3.177億美元,2022年至2030年的分析期間年複合成長率為7.8%。其他值得注意的地域市場包括日本和加拿大,預計 2022 年至 2030 年將分別成長 7.6% 和 7.1%。在歐洲,德國預計年複合成長率約為 6.4%。

受訪企業示例

  • Abcam PLC
  • AMS Biotechnology(Europe)Ltd.(AMSBIO)
  • Biovision Inc.
  • Cell Biolabs, Inc.
  • Enzo Biochem, Inc.
  • Merck KgaA
  • MilliporeSigma
  • Oxford Biomedical Research, Inc.
  • Promega Corporation
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

目錄

第1章 調查方法

第2章 執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 競爭

簡介目錄
Product Code: MCP13802

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Oxidative Stress Assays Market to Reach $1.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Oxidative Stress Assays estimated at US$971.6 Million in the year 2022, is projected to reach a revised size of US$1.9 Billion by 2030, growing at aCAGR of 8.5% over the period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 9.3% CAGR and reach US$1.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 7.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $288.8 Million, While China is Forecast to Grow at 7.8% CAGR

The Oxidative Stress Assays market in the U.S. is estimated at US$288.8 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$317.7 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.6% and 7.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Select Competitors (Total 11 Featured) -

  • Abcam PLC
  • AMS Biotechnology (Europe) Ltd. (AMSBIO)
  • Biovision Inc.
  • Cell Biolabs, Inc.
  • Enzo Biochem, Inc.
  • Merck KgaA
  • MilliporeSigma
  • Oxford Biomedical Research, Inc.
  • Promega Corporation
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Oxidative Stress Assays - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for ELISA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Flow Cytometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Microscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for High-Content Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for High-Content Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for High-Content Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Label-Free Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Label-Free Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Label-Free Detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Oxidative Stress Assays Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Oxidative Stress Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Oxidative Stress Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for Oxidative Stress Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: World 16-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: World 16-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: World 16-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Oxidative Stress Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Oxidative Stress Assays by Technology - Percentage Breakdown of Value Sales for ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection for the Years 2014, 2023 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Oxidative Stress Assays by Offering - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Oxidative Stress Assays by Offering - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Oxidative Stress Assays by Offering - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Oxidative Stress Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Oxidative Stress Assays by Technology - Percentage Breakdown of Value Sales for ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection for the Years 2014, 2023 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Oxidative Stress Assays by Offering - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Oxidative Stress Assays by Offering - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Oxidative Stress Assays by Offering - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Oxidative Stress Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
    • Oxidative Stress Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Oxidative Stress Assays by Technology - Percentage Breakdown of Value Sales for ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection for the Years 2014, 2023 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Oxidative Stress Assays by Offering - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Oxidative Stress Assays by Offering - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Oxidative Stress Assays by Offering - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for Oxidative Stress Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
    • Oxidative Stress Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: China 16-Year Perspective for Oxidative Stress Assays by Technology - Percentage Breakdown of Value Sales for ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection for the Years 2014, 2023 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Oxidative Stress Assays by Offering - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Oxidative Stress Assays by Offering - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: China 16-Year Perspective for Oxidative Stress Assays by Offering - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: China 16-Year Perspective for Oxidative Stress Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
    • Oxidative Stress Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Oxidative Stress Assays by Technology - Percentage Breakdown of Value Sales for ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection for the Years 2014, 2023 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Oxidative Stress Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Oxidative Stress Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Oxidative Stress Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Oxidative Stress Assays by Offering - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Oxidative Stress Assays by Offering - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Oxidative Stress Assays by Offering - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Oxidative Stress Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
    • Oxidative Stress Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: France 16-Year Perspective for Oxidative Stress Assays by Technology - Percentage Breakdown of Value Sales for ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection for the Years 2014, 2023 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Oxidative Stress Assays by Offering - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Oxidative Stress Assays by Offering - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: France 16-Year Perspective for Oxidative Stress Assays by Offering - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: France 16-Year Perspective for Oxidative Stress Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
    • Oxidative Stress Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Oxidative Stress Assays by Technology - Percentage Breakdown of Value Sales for ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection for the Years 2014, 2023 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Oxidative Stress Assays by Offering - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Oxidative Stress Assays by Offering - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Oxidative Stress Assays by Offering - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for Oxidative Stress Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Oxidative Stress Assays by Technology - Percentage Breakdown of Value Sales for ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection for the Years 2014, 2023 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Oxidative Stress Assays by Offering - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Oxidative Stress Assays by Offering - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Oxidative Stress Assays by Offering - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for Oxidative Stress Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Oxidative Stress Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 122: UK Recent Past, Current & Future Analysis for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Oxidative Stress Assays by Technology - Percentage Breakdown of Value Sales for ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection for the Years 2014, 2023 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Oxidative Stress Assays by Offering - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Oxidative Stress Assays by Offering - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Oxidative Stress Assays by Offering - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: UK 16-Year Perspective for Oxidative Stress Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Oxidative Stress Assays by Technology - Percentage Breakdown of Value Sales for ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection for the Years 2014, 2023 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Oxidative Stress Assays by Offering - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Oxidative Stress Assays by Offering - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Oxidative Stress Assays by Offering - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Oxidative Stress Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Oxidative Stress Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Oxidative Stress Assays by Technology - Percentage Breakdown of Value Sales for ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection for the Years 2014, 2023 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Oxidative Stress Assays by Offering - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Oxidative Stress Assays by Offering - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Oxidative Stress Assays by Offering - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Oxidative Stress Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Oxidative Stress Assays by Technology - ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Oxidative Stress Assays by Technology - Percentage Breakdown of Value Sales for ELISA, Chromatography, Flow Cytometry, Microscopy, High-Content Screening and Label-Free Detection for the Years 2014, 2023 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Oxidative Stress Assays by Offering - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Oxidative Stress Assays by Offering - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 154: Rest of World 16-Year Perspective for Oxidative Stress Assays by Offering - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2023 & 2030
    • TABLE 155: Rest of World Recent Past, Current & Future Analysis for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Rest of World Historic Review for Oxidative Stress Assays by End-Use - Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 157: Rest of World 16-Year Perspective for Oxidative Stress Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic Research Institutes, Clinical Laboratories, Contract Research Organizations and Other End-Uses for the Years 2014, 2023 & 2030

IV. COMPETITION